USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medizinische Hochschule Hannover

USPTO PatentsView assignee record — 68 granted patents across 37 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

68
Total patents granted
37
CPC technology areas
13.2
Avg claims per patent
+13%
5-year filing velocity

The verdict

Medizinische holds 68 US patents across 37 technology areas — rank #5,092 of 50,000 tracked assignees.

#5,092
of 50,000 US assignees by volume
Top 15%
by Innovation Score (49.1/100)
13.2
avg claims per patent
+13%
filing velocity, last 5 yrs

Portfolio overview

MEDIZINISCHE HOCHSCHULE HANNOVER has been granted 68 US utility patents between 2015 and 2024, placing MEDIZINISCHE HOCHSCHULE HANNOVER at rank #5,092 across all assignees tracked by PlainPatent. This portfolio spans 37 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.2 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, MEDIZINISCHE HOCHSCHULE HANNOVER is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 49.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 36 grants, compared with 32 in the 2015–2019 window — a +13% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. MEDIZINISCHE HOCHSCHULE HANNOVER's 13.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 37 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark MEDIZINISCHE HOCHSCHULE HANNOVER against peers pursuing similar technology classes.

How does MEDIZINISCHE compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows MEDIZINISCHE holds 68 patents — placing it at rank #5,092 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

MEDIZINISCHE's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

49 Top 15% higher than 85% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

051015 2015201620172018201920202021202220232024 7
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
MEDIZINISCHE HOCHSCHULE HANNOVER patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 5 7.4%
2016 3 4.4%
2017 7 10.3%
2018 9 13.2%
2019 8 11.8%
2020 7 10.3%
2021 10 14.7%
2022 11 16.2%
2023 1 1.5%
2024 7 10.3%

Which technologies does MEDIZINISCHE HOCHSCHULE HANNOVER patent most?

Top 15 of 37 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#5,092

Across all tracked assignees

Innovation Score

49.1 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does MEDIZINISCHE HOCHSCHULE HANNOVER hold?
MEDIZINISCHE HOCHSCHULE HANNOVER holds 68 US granted patents filed between 2015 and 2024, spanning 37 technology areas.
What is MEDIZINISCHE HOCHSCHULE HANNOVER's Innovation Score?
MEDIZINISCHE HOCHSCHULE HANNOVER has an Innovation Score of 49.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does MEDIZINISCHE HOCHSCHULE HANNOVER focus on?
MEDIZINISCHE HOCHSCHULE HANNOVER's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 35 patents. The company has filed patents in 37 CPC subclasses total.
Is MEDIZINISCHE HOCHSCHULE HANNOVER's patent filing rate increasing or decreasing?
MEDIZINISCHE HOCHSCHULE HANNOVER's recent filing velocity is +13% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for MEDIZINISCHE HOCHSCHULE HANNOVER's patents?
MEDIZINISCHE HOCHSCHULE HANNOVER's patents average 13.2 claims each. This falls within the standard range, providing solid legal coverage.
How is the MEDIZINISCHE HOCHSCHULE HANNOVER patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How to use this portfolio

Medizinische's 68 grants land it in the top 15% by Innovation Score — but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance — Medizinische ranks #5,092 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61K — see who else leads that technology area. A61K leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity — not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView — the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) — the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search — the official interface to verify the status of any individual patent. ppubs.uspto.gov